AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer

Clinical trial NCT05617755 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05617755
Sponsor: Arsenal Biosciences, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Ovarian Epithelial Ovarian Neoplasms Fallopian Tube Neoplasms Peritoneal Neoplasms Neoplasms, Glandular and Epithelial Ovarian Diseases Genital Neoplasm, Female Abdominal Neoplasm Recurrence

Start date: 2022-11-29
Primary completion: 2024-09-30
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.